Building three-dimensional structures of HIV-1 coreceptor CCR5 and its interaction with antagonist TAK779 by comparative molecular modeling

被引:0
作者
Huang, XQ
Jiang, HL
Luo, XM
Chen, KX [1 ]
Ji, RY
Cao, Y
Pei, G
机构
[1] Shanghai Inst Mat Med, Shanghai 200031, Peoples R China
[2] Suzhou Univ, Dept Chem, Suzhou 215006, Peoples R China
[3] Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 2000年 / 21卷 / 06期
关键词
TAK; 779; CCR5; receptor; molecular structure; HIV-1; computer aided design;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To study the mechanism of interaction of CCR5 receptor with its antagonist TAK779. METHODS: Comparative molecular modeling has been used to develop the 3D-structural models of CCR5 receptor and its complex with TAK779. Molecular mechanics has been applied to optimize the above molecular models. Quantum mechanics has been utilized to calculate the structural information of TAK779. DOCK4. 0 program is employed to dock the TAK779 molecular into the binding site of CCR5 receptor. RESULTS: The SD-structural model of CCR5 receptor is constructed using the SD-model of frog rhodopsin as a template. The binding pocket is situated in the transmembrane helices 3, 5, 6, and 7, and it is composed of conserved residues of Tyr108, Gly111, Ser114, Glu283, Gly286, and Cys290, and conservatively varied residues including Thr105, Leu107, Phe112, Gly115, Lys197, and Met287. O-1, N-7, N-17, and O-19 of TAK779 are the active center of TAK779. The pyran cycle and the aminium group of TAK779 interact with residues in the binding pocket of CCR5 receptor, the other part of TAK779 interacts with residues from the extracellular loops of CCR5. The binding energy of TAK779 with CCR5 is - 51. 606 kcal/mol. CONCLUSION: The model constructed and the interaction mode reported in the present study are useful in further understanding the molecular mechanism of receptor-virus recognition and designing new inhibitors of HIV-1 infection.
引用
收藏
页码:521 / 528
页数:8
相关论文
共 15 条
[1]   A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].
Baba, M ;
Nishimura, O ;
Kanzaki, N ;
Okamoto, M ;
Sawada, H ;
Iizawa, Y ;
Shiraishi, M ;
Aramaki, Y ;
Okonogi, K ;
Ogawa, Y ;
Meguro, K ;
Fujino, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703
[2]  
EWING TJA, 1998, DOCK COMPUTER PROGRA
[3]   A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 [J].
Farzan, M ;
Choe, H ;
Vaca, L ;
Martin, K ;
Sun, Y ;
Desjardins, E ;
Ruffing, N ;
Wu, LJ ;
Wyatt, R ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1160-1164
[4]  
*GUSS INC, 1998, GAUSS COMP PROGR VER
[5]   Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsin [J].
Herzyk, P ;
Hubbard, RE .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (04) :741-754
[6]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659
[7]   A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN [J].
KYTE, J ;
DOOLITTLE, RF .
JOURNAL OF MOLECULAR BIOLOGY, 1982, 157 (01) :105-132
[8]   Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function [J].
Lee, B ;
Sharron, M ;
Blanpain, C ;
Doranz, BJ ;
Vakili, J ;
Setoh, P ;
Berg, E ;
Liu, G ;
Guy, HR ;
Durell, SR ;
Parmentier, M ;
Chang, CN ;
Price, K ;
Tsang, M ;
Doms, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9617-9626
[9]  
*MOL SIM INC, 1997, INS COMP PROGR VERS
[10]   Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha [J].
Raport, CJ ;
Gosling, J ;
Schweickart, VL ;
Gray, PW ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17161-17166